CD44, IL-33, and ST2 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility in the Chinese Population
The interleukin- (IL-) 33/ST2 axis plays a pivotal role in tumorigenesis through influencing cancer stemness and other mechanisms. CD44 is one of the critical markers of hepatocellular carcinoma (HCC) among the cancer stem cells (CSCs). There is still a lack of CD44 gene single-nucleotide polymorphi...
Main Authors: | Xiaolan Pan, Meiqin Li, Lei Huang, Dan Mo, Yihua Liang, Zhaodong Huang, Bo Zhu, Min Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/2918517 |
Similar Items
-
CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
by: Ying-Erh Chou, et al.
Published: (2014-01-01) -
The Association between PON1 (Q192R and L55M) Gene Polymorphisms and Risk of Cancer: A Meta-Analysis Based on 43 Studies
by: Xiaolan Pan, et al.
Published: (2019-01-01) -
CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
by: Ying-Erh Chou, et al.
Published: (2014-01-01) -
Interaction between CD44 gene polymorphisms and environmental factors on oral cancer susceptibility
by: Ying-Erh Chou, et al.
Published: (2014) -
The IL-33/ST2 pathway suppresses murine colon cancer growth and metastasis by upregulating CD40 L signaling
by: Ping Luo, et al.
Published: (2020-07-01)